Introduction
============

Diarrheal diseases including cholera are a major cause of morbidity and mortality in developing countries worldwide (Kosek et al. ([@B15]); Bryce et al., [@B4]). Several million cases and over 120,000 deaths result annually from cholera caused by the marine bacterium *Vibrio cholerae* (World Health Organization, [@B42]). Upon ingestion of contaminated water, *V. cholerae* passes through the gastric acid barrier in the stomach and colonizes the small intestine (Zhu and Mekalanos, [@B45]) with the help of toxin-coregulated pili (TCP). The bacteria secrete cholera toxin (CT) that, when internalized by epithelial cells of the small intestine, causes major water efflux into the gut lumen (Sack et al., [@B31]). As a result, *V. cholerae* leaves the human host during diarrheal purges (Larocque et al., [@B16]).

Over 200 different *V. cholerae* serogroups have been classified so far, but only the O1 serogroup strains spread globally and cause pandemics. Bacteria from this serogroup (and others like O139) use TCP to autoaggregate in the small intestine and secrete CT (Sack et al., [@B31]). Besides CT and TCP, *V. cholerae* O1 serogroup strains require accessory toxins to cause cholera, as live vaccine strains with deleted CT and TCP genes still cause severe diarrhea (Fullner et al., [@B11]). These accessory toxins include virulence factors such as repeats-in-toxin (RTX) toxin, the zinc-dependent metalloprotease, hemagglutinin/protease (HA/protease), and HlyA hemolysin (Fullner et al., [@B11]). In contrast, most other serogroups (so-called non-O1, non-O139) are either avirulent or cause severe gastroenteritis (often in the absence of cholera toxin), but have not yet spread globally (Dziejman et al., [@B9]). In an attempt to identify virulence factors that function independently of CT and TCP, we studied the genetic basis for the virulent behavior of *V. cholerae* O37 serogroup strain V52, a highly virulent strain that caused 460 cases and 125 deaths during a local outbreak in Sudan in 1968 (Zinnaka and Carpenter, [@B46]). Using the social amoeba *Dictyostelium discoideum* as a host model, we found that the type VI secretion system (T6SS) functions as a potent virulence determinant (Pukatzki et al., [@B28]).

It is not clear if expression of the T6SS is restricted to certain *V. cholerae* serogroups or whether it contributes to the human disease cholera. In this *Perspective Article*, we evaluate the possible role of the T6SS in the disease cholera by analyzing the presence of T6SS gene clusters in the genomes of various *V. cholerae* strains, including those responsible for the sixth (1899--1923) and the current seventh pandemic (\>1961) (Sack et al., [@B31]).

The *V. Cholerae* T6SS
======================

Using the social amoeba *D. discoideum* as a host model, we identified a large conserved cluster of 17 genes (VCA0107--0123) plus two smaller auxiliary clusters (VCA0017--VCA0021 and VC1415--VC1416) in the genome of *V. cholerae* strain V52 that encode a novel secretion system -- the T6SS (Pukatzki et al., [@B28]).

Although most genes in the *V. cholerae* type VI clusters (Figure [1](#F1){ref-type="fig"}A) are conserved hypothetical genes with unknown functions, a few genes have putative functions as suggested by bioinformatic analysis (Pukatzki et al., [@B29]), and a series of gene deletions linked these genes to virulence toward *D. discoideum* (Pukatzki et al., [@B28], [@B27]). Based on bioinformatics and experimental data, T6SS genes fall into three functional classes: structural, regulatory, and effector.

![**The *V. cholerae* Type VI Secretion System (T6SS)**. **(A)** The T6SS gene clusters. The three gene clusters contain genes of predicted (blue) and unknown (gray) functions. VCA0117 encodes the gene designated *vasH*. Also shown is the VasH-dependent regulation of the T6SS genes. (IHF, integration host factor). **(B)** Model for T6SS mechanics. Structural components form the base of the T6SS in the bacterial inner and outer membrane. A surface-exposed Hcp tube decorated with a VgrG trimer punctures a vesicular membrane to translocate effectors into the host cell (see text for details).](fmicb-01-00117-g001){#F1}

Structural components
---------------------

We do not know how the T6SS proteins assemble to form a secretion apparatus; however, several type VI proteins are structurally related to components of the T4 bacteriophage tail complex (Kanamaru et al., [@B14]). This protein complex is located at the distal tip of the syringe-shaped phage tail and allows the phage to puncture the bacterial envelope and inject its DNA into a bacterium. We speculate that bacteria deploy their type VI secretion machinery in a similar fashion to puncture host membranes. We identified four T6SS components that show high structural homology with T4 bacteriophage proteins. These are the hemolysin-coregulated protein (Hcp) and three VgrG (valine-glycine-repeat protein G) proteins (VgrG1--3). Export of these four proteins requires the putative structural gene product VasK, which shows high similarity to the IcmF component of the type IV secretion system (T4SS) of *Legionella pneumophila* (Segal et al., [@B35]).

Bioinformatic analyses predict that the T6SS contains a tube-like structure. Monomers that could assemble into such a tube are the small 19-kD Hcp-proteins encoded by the two alleles VCA0017 and VC1415, which share 98% similarity and encode identical proteins. In support of this model, Ballister et al. ([@B2]) found that recombinant Hcp from *Pseudomonas aeruginosa* readily assembles *in vitro* into hexameric rings to form nanotubes. Our bioinformatic analyses of VgrGs revealed that these T6SS components are members of a novel protein family (Pukatzki et al., [@B27]). The recently solved crystal structure (Leiman et al., [@B17]) of a VgrG molecule from uropathogenic *Escherichia coli* confirmed our bioinformatic prediction that VgrG proteins form a trimeric cap similar to the cell-puncturing device of the T4 bacteriophage (Pukatzki et al., [@B27]) (Figure [1](#F1){ref-type="fig"}B).

The current model (Figure [1](#F1){ref-type="fig"}B) proposes that after assembly of the VgrG-cap is completed, Hcp molecules form a hexameric ring that may dock underneath the VgrG trimer to build a doublet ring with a continuous central pore. As more hexameric Hcp rings form and attach to the existing structure, the Hcp tube, decorated with a single trimeric VgrG-cap at its tip, may be pushed across the *V. cholerae* membrane into the extracellular space. Interestingly, two VgrGs (VgrG-1 and VgrG-3) have evolved additional functions, such as actin-crosslinking, and serve as effectors when pushed into the host cytosol (Ma et al., [@B19]). Because the VgrG-cap lacks a channel, the tube is likely to be a gated complex (Leiman et al., [@B17]), in which case, the cap would need to dissociate from the complex for soluble substrates to pass through the Hcp channel. Recent findings by Ma et al. suggest that the actin-crosslinking domain of VgrG-1 is translocated *in vivo*, because infection of infant mice with *V. cholerae* strain V52 results in a T6SS-dependent inflammatory response and actin-crosslinking in cells of the small intestine (Ma and Mekalanos, [@B20]).

Regulatory components
---------------------

Our transposon mutagenesis screen identified two type VI regulators -- VasH, positioned in the center of the large type VI cluster (Figure [1](#F1){ref-type="fig"}A), and *rpoN*, encoding the alternative sigma factor-54 (Pukatzki et al., [@B28]). Both *vasH* and *rpoN* mutants were attenuated in their ability to infect and kill *D. discoideum*. As *vasH* and *rpoN* mutant phenotypes are indistinguishable, they may act in the same regulatory pathway (Pukatzki et al., [@B28]).

VasH encodes a 59-kD protein that has the hallmarks of a sigma-54-dependent regulator with domains that may function as (i) an N-terminal regulatory domain, (ii) an AAA +  central core with a putative ATP hydrolysis function, and *(iii)* a DNA binding domain with a conserved helix-turn-helix motif (Shingler, [@B37]; Schumacher et al., [@B33]) (Figure [2](#F2){ref-type="fig"}B). A *vasH*-null strain does not produce Hcp and is avirulent toward *D. discoideum* (Pukatzki et al., [@B28]). Analyses of both *hcp* promoters revealed conserved binding sites for integration host factor and sigma-54 (Williams et al., [@B41]). Integration host factor bends DNA such that a sigma-54 activator bound to a distant upstream activation sequence can directly interact with the promoter-bound sigma-54 of the RNA polymerase-holoenzyme (Stonehouse et al., [@B38]). We predict that the same mechanism is true for VasH, which is highly expressed during human infections (Lombardo et al., [@B18]). *VasH* is polymorphic in *V. cholerae* (Figures [2](#F2){ref-type="fig"}B and C) and it will be exciting to determine if this heterogeneity contributes to the strain-specific regulation of T6SS genes.

![**T6SS clusters in *V. cholerae* strains with sequenced genomes**. **(A)** Genomic alignments. Nucleotide sequences used for this study were obtained from Broad Institute and NCBI databases and compared with the blastn program from the stand-alone NCBI BLAST application (version 2.2.21). In-house Perl scripts were written to parse BLAST output and to compare genomic sequences of gene models for variations. BioPerl (<http://www.bioperl.org/>) modules were used. Regions containing the T6SS clusters of various *V. cholerae* strains (names on the left) were aligned. Each gene is indicated by a box in a color distinct for a particular strain. A vertical bar and an asterisk indicate the 3′-end of a truncated gene. Codon insertions are indicated by red triangles, while deletions are indicated by yellow triangles with numbers that indicate the insertion/deletion size (number of codons). Rough ends of a gene indicate that the complete sequence was not available. **(B)** Polymorphic domains of VasH. Graphical depiction of VasH from the O37 serogroup strain V52 (V52_VasH) with its putative N-terminal regulatory domain (blue), core sigma-54 activator domain (pink), and C-terminal helix-turn-helix (HTH) domain (yellow) (drawn to scale). Conserved amino acid substitutions are indicated by arrows. The residue and its position in VasH of V52 is indicated below the line and the substitutions found in other strains are indicated above the arrowhead. **(C)** Allelelic VasH variants. Listed are VasH variants of different *V. cholerae* strains compared to VasH in V52. Amino acid substitutions are listed for each variant. Font color indicates in which of the three domains the substitution is located.](fmicb-01-00117-g002){#F2}

Effector components
-------------------

It is not known if molecules commonly called "effectors" are transported through the central channel of the type VI apparatus. Candidates for such soluble effectors are the autoinducer-2 (AI-2) binding protein RbsB from *Rhizobium leguminosarum* (Bladergroen et al., [@B3]), EvpP from *Edwardsiella tarda* (Zheng and Leung, [@B44]), and AaiC from enteroaggregative *E. coli* (Dudley et al., [@B8]); however, *V. cholerae* does not carry homologs of these putative T6SS substrates.

Distribution of T6SS Clusters Among *V. Cholerae* Strains
=========================================================

While the gene content differs tremendously between *V. cholerae* serogroups and strains in respect to virulence genes -- including the genes encoding cholera toxin or the genes encoding the type III secretion system (T3SS) (Tam et al., [@B40]) -- all *V. cholerae* serogroups sequenced thus far contain all three gene clusters involved in the T6SS (Figure [2](#F2){ref-type="fig"}A) (Pukatzki et al., [@B28]).

To assess the distribution of T6SS clusters in *V. cholerae* genomes, we compared *V. cholerae* strains for which sequenced genomes are available. As illustrated in Figure [2](#F2){ref-type="fig"}A, we included the O1 classical strain O395 (sixth pandemic), O1 El Tor strains M66-2 (pre-seventh pandemic), and N16961 (seventh pandemic), the El Tor strain MJ-1236 that carries a classical biotype CTX prophage (so-called hybrid strain), and the non-O1/non-O139 strains V52 (O37 serogroup) and MZO-2 (O14 serogroup). Both V52 (Zinnaka and Carpenter, [@B46]) and MZO-2 (GenBank Taxonomy No. 417398) have been responsible for gastrointestinal illness that failed to become pandemic. The genome of V52 was used as the reference genome as this strain produces a functional T6SS (Pukatzki et al., [@B28]). The large T6SS cluster of N16961 contains 285 single nucleotide substitutions of which 49 are non-synonymous substitutions that result in amino acid changes in all 17 genes of the *V. cholerae* type VI cluster.

We found a complete T6SS complement in each strain tested. The classical O1 strain O395 has four non-sense mutations, including a mutation in VCA0120 (*vasK*) that is essential for T6SS function (Pukatzki et al., [@B28]); thus the T6SS of the O1 strain O395 may be non-functional. Interestingly, one gene, VCA0122, encodes an 80-amino acid polypeptide in N16961, O395, M66-2, MJ-1236, and MZO-2, while the V52 genome encodes a shorter 70-residue protein with a unique 27 residue C-terminus. It must be noted that truncation of the VCA0122-encoded protein in V52 does not correlate with impaired T6SS function, as V52 readily engages in T6SS-mediated toxicity (Pukatzki et al., [@B28]). The unique VCA0122-encoded protein may contribute to the constitutive production of the V52 T6SS. The satellite cluster VCA0017-22 appears to be intact in all strains. While *hcp-2* (VCA0017) and *vgrG-2* (VCA0018) are highly polymorphic genes encoding full-length products, VCA0020 contains three extra codons in M66-2 and two extra codons in MZO-2 plus a one-codon deletion. The genes *hcp-1* (VC1415) and *vgrG-1* (VC1416) are highly conserved and share identical sequences in V52, N16961, M66-2, and MJ-1236. *Hcp-1* of O395 shares an identical sequence with these strains, however its *vgrG-1* contains a 16-codon in-frame deletion and a non-sense mutation. Furthermore, VgrG-1 of MZO-2 is highly polymorphic and differs from V52 in 15 residues.

From a genomic perspective there is reason to believe that many *V. cholerae* strains, including post-sixth pandemic strains, carry functional T6SSs. Even though important T6SS genes are polymorphic, the vast majority of nucleotide substitutions are synonymous and do not alter the sequence of the encoded protein. Substitutions that alter the protein are for the most part conserved. The fact that most mutations are silent and do not lead to truncated gene products suggests to us that *V. cholerae* is subjected to selective pressure that maintains an operative T6SS. It should be noted that even though V52 belongs to the non-O1/non-O139 group of *V. cholerae*, it is more closely related to the classical O1 strain O395 than to the El Tor strain N16961 (Chun et al., [@B5]); yet, O395 accumulated at least four non-sense mutations in the T6SS cluster while N16961 accumulated none. Thus, unlike N16961, O395 might have lost the need for a functional T6SS and has accumulated disabling mutations in the T6SS cluster.

Expression of the T6SS Complement
=================================

If some endemic and pandemic *V. cholerae* strains carry a functional T6SS complement, we need to understand why some strains use their system constitutively under laboratory conditions while others do not (Pukatzki et al., [@B28]). One explanation is that strains regulate their systems differently: while some clinical and environmental *V. cholerae* strains express the T6SS constitutively, pandemic strains may be more selective. There is precedence for strain-specific regulation of virulence genes in *V. cholerae*: the ToxR regulons of classical and El Tor strains require different *in vitro* growth conditions to express the genes encoding CT and TCP, while the classical O1 strain 569B expresses CT and TCP constitutively (Majumder et al., [@B22]). We hypothesize that the T6SS behaves similarly such that pandemic strains require yet to be identified signals, while V52 expresses its T6SS in the absence of such signals.

The fact that the T6SS genes identified in V52 are maintained in the pandemic El Tor strain N16961 implies that the T6SS genes are under selection in N16961 and have not drifted. One reason that N16961 does not kill amoebae may be that this strain uses a regulatory T6SS network that is not activated under laboratory conditions. Genomic comparison of *vasH* (VCA0117), the gene that encodes the T6SS regulator VasH, revealed that VasH is polymorphic and differs between strains (Figures [2](#F2){ref-type="fig"}B and C). The polymorphisms occur in interesting places: 10 conserved amino acid substitutions give rise to 10 variants. Five substitutions occur in the putative regulatory N-terminal domain, and the only substitution in the activator core domain is located just 27 residues downstream from the Walker B motif. Three substitutions are located between the core domain and the DNA-binding domain. It will be interesting to see if the polymorphic nature of the T6SS cluster, including *vasH*, accounts for the different utilization of this virulence determinant.

A Working Model
===============

If the T6SS is a universal feature used by *V. cholerae*, then how does the T6SS contribute to the persistent and virulent behavior of *V. cholerae*? We recently demonstrated that *V. cholerae* uses its T6SS to kill eukaryotic phagocytes (Pukatzki et al., [@B28]). The structural homology of the T6SS and the cell-puncturing device of the T4 bacteriophage suggests that the T6SS can target bacteria, an activity that has been demonstrated experimentally for *V. cholerae* (MacIntyre et al., [@B21]), *P. aeruginosa* and *Burkholderia thailandensis* (Hood et al., [@B13]; Schwarz et al., [@B34]).

We propose that *V. cholerae* uses its T6SS to outcompete bacterial neighbors as well as eukaryotic predators like mammalian immune cells and amoebae. As shown in Figure [3](#F3){ref-type="fig"}, *V. cholerae* must colonize the small intestine to initiate an infection. However, the epithelial lining of the small intestine contains commensal bacteria, some of which secrete products harmful to *V. cholerae* (step 1). *V. cholerae* passes the gastric acid barrier can reach the lumen of the small intestine (step 2) where it may turn on its T6SS to kill commensal bacteria to clear competitors from epithelial surfaces required for colonization (step 3). Activation of the T6SS likely involves the putative transcriptional activator VasH, which we hypothesize activates RNA polymerase bound to the sigma-54 binding sites of selective promoters. We do not know how VasH is regulated, but bioinformatics analysis allows us to speculate that VasH may function as the receiver module of a yet to be identified two-component system that is activated in response to unknown external stimuli. Once activated, VasH triggers the expression of genes encoding important structural proteins such as Hcp and VgrG. As *V. cholerae* multiplies and continues to kill adjacent commensals, it begins to secrete cholera toxin (step 4). The infection is recognized by the host, and phagocytic immune cells invade the area to clear the infection. As *V. cholerae* is phagocytosed, the T6SS is activated to kill the infected immune cells (step 5), thereby allowing the infection to proceed. If this model is correct, it would be interesting to determine if there are distinct environmental signals that activate the T6SS depending on whether they are challenged by immune cells or other prokaryotic competitors. The release of cholera toxin triggers massive water efflux into the gut lumen, and *V. cholerae* leaves the small intestine during diarrheal purges (step 6). *V. cholerae* leaving the human host is primed to ward off bacterial and amoeboid predators in the environment they are about to encounter (step 7).

![**A model for the role of the T6SS in persistence and virulence of *V. cholerae***. (1) The small intestine colonized with commensal bacteria is (2) invaded by *V. cholerae* cells that passed the gastric acid barrier. (3) Upon descent into the ducts between adjacent villi of the small intestine, *V. cholerae* assembles the T6SS on its surface (indicated by black spikes) in order to kill commensal microorganisms. (4) The sterile patches generated allow *V. cholerae* to colonize and multiply. (5) Incoming immune cells that ingest *V. cholerae* are killed by the T6SS-mediated toxicity, allowing the infection to proceed. (6) Secretion of cholera toxin results in massive water efflux into the host lumen, and *V. cholerae* cells leave the human host during diarrheal purges. (7) *V. cholerae* exiting the body maintain T6SS activation in preparation for bacterial and eukaryotic predators in the environment.](fmicb-01-00117-g003){#F3}

Conclusions
===========

The predominant presence of T6SS genes in *V. cholerae* genomes suggests a fundamental function for this pathway. Based on the toxicity displayed by this secretion system in V52, we hypothesize that the T6SS and toxin translocation play key roles in allowing *V. cholerae* to outcompete other bacteria and phagocytic cells (i.e., amoebae and macrophages) and thus persist in human hosts and in the environment. If this hypothesis is correct, the T6SS would maximize the pathogenicity imposed by strain-specific cholera toxin and other virulence factors. As many environmental and enteric Gram-negative proteobacteria carry T6SS genes (Folkesson et al., [@B10]; Gray et al., [@B12]; Das and Chaudhuri, [@B6]; Nano et al., [@B25]; Rao et al., [@B30]; Parsons and Heffron, [@B26]; Dudley et al., [@B8]; Mougous et al., [@B23]; de Bruin et al., [@B7]; Mougous et al., [@B24]; Schell et al., [@B32]; Shalom et al., [@B36]; Zheng and Leung, [@B44]; Aubert et al., [@B1]; Suarez et al., [@B39]; Yen et al., [@B43]), future research will determine if use of the T6SS for competition purposes is a common theme among microbes.
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